TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 4 | 2 | -4 | -28 | -54 | -86 | -28 |
| P | %wins | 100 | 50 | 0 | 0 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/15 11:45 | 8/18/15 | PTX | Pernix Therapeutics Holdings, Inc. | MD | Health | Drug | Pharmaceutical Preparations | Drysdale Douglas | NJ | DO | CEO | P | 40 | 4.69 | 8 | 9 | 10 | 95 | D | 58 | -34 | -47 | -26 | -14 | -4 | -7 | -1 | 3 | -3 | -3 | -31 | -55 | -87 |
5/6/15 16:58 | 5/6/15 | PTX | Pernix Therapeutics Holdings, Inc. | MD | Health | Drug | Pharmaceutical Preparations | Drysdale Douglas | NJ | DO | CEO | P | 102 | 6.40 | 14 | 16 | 20 | 97 | D | 75 | 43 | -35 | -24 | -35 | -36 | -10 | 0 | 5 | 7 | -5 | -24 | -53 | -84 |
8/12/14 07:16 | 8/8/14 | PTX | Pernix Therapeutics Holdings, Inc. | MD | Health | Drug | Pharmaceutical Preparations | Drysdale Douglas | NJ | DO | CEO | M.d | 392 | 2.09 | 3 | 188 | 81 | D | -5 | 118 | 123 | 45 | -24 | -16 | -9 | 0 | 5 | 3 | 10 | 33 | 28 | -28 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |